Antitargets and drug safety /
I tiakina i:
| Ētahi atu kaituhi: | , , |
|---|---|
| Hōputu: | Tāhiko īPukapuka |
| Reo: | Ingarihi |
| I whakaputaina: |
Weinheim, Germany :
Wiley-VCH,
[2015]
|
| Rangatū: | Methods and principles in medicinal chemistry ;
v. 66. |
| Ngā marau: | |
| Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Rārangi ihirangi:
- section 1. General concept for target-based safety assessment
- section 2. Hepatic side effects
- section 3. Cardiovascular side effects
- section 4. Kinase antitargets
- section 5. Examples of clinical translation.